All Stories

  1. Electroencephalography in the diagnosis and management of treatment-resistant depression with comorbid epilepsy: a novel strategy
  2. Drug-Resistant Epilepsy and Obstructive Sleep Apnea: Exploring a Link Between the Two
  3. Pathophysiology of the comorbidity of glaucoma with obstructive sleep apnea: A postulation
  4. A critical analysis of the purported role of hypoxaemia in the comorbidity of obstructive sleep apnoea and epilepsy
  5. Letter to the Editor Regarding “Deep Brain Stimulation in Intractable Epilepsy: Pedunculopontine Nucleus versus Thalamic Nuclei: A Perspective”
  6. MAJOR CONTRIBUTING ANTHROPOMETRIC PARAMETER(S) FOR REGIONAL VARIATION IN BODY MASS INDEX IN COASTAL AND PLAIN REGIONS OF INDIA: A PILOT COHORT STUDY
  7. Pedunculopontine Nucleus Stimulation in Intractable Epilepsy
  8. EEG in deep brain stimulation
  9. Expanding the therapeutic spectrum of anterior thalamic nucleus deep brain stimulation in intractable epilepsy: A postulation
  10. Intractability in Epilepsy
  11. Publishing in Epilepsy & Behavior: My personal experience
  12. Polysomnographic Assessment of Epileptic State
  13. Deep-Brain Stimulation in Intractable Epilepsy: Pedunculopontine Nucleus Versus Thalamic Nuclei: A Perspective
  14. Deep Brain Stimulation in Intractable Epilepsy
  15. EEG modifications and enhancement
  16. Intractable epilepsy: Deep brain stimulation (DBS)-based electrophysiological biomarker
  17. Pedunculopontine nucleus (PPN) stimulation in intractable epilepsy: Evidence-related programming
  18. Revision of the name of ‘epilepsy’ to ‘electroencephalic disorder’: Hope for improved quality of life in patients with ‘epilepsy’
  19. Deep brain stimulation in intractable epilepsy: Postulated optimal stimulation parameters
  20. Replacement of electroencephalography with polysomnography in epilepsy for improved assessment: Need of the hour
  21. Rapid eye movement (REM) sleep: A reliable biomarker of intractability in epilepsy
  22. Pedunculopontine nucleus stimulation: A novel therapeutic technique in intractable epilepsy
  23. Adrenocorticotrophic hormone (ACTH) therapy in infantile spasms (IS): Current evidence for its superior therapeutic efficacy
  24. Pedunculopontine nucleus stimulation in intractable epilepsy: Simulation of nature's antiepileptic role and mechanism
  25. Pedunculopontine nucleus stimulation: A novel adjunctive therapeutic approach in intractable epilepsy
  26. Pedunculopontine nucleus stimulation: Potent therapeutic role in intractable epilepsy
  27. Treatment of interictal epileptiform discharges (IEDs) in patients with cerebral palsy for an improved prognostic outcome and quality of life: Emerging evidence
  28. Superior therapeutic efficacy of adrenocorticotrophic hormone (ACTH) in infantile spasms: Emerging evidence
  29. EEG spike versus EEG sharp wave: Differential clinical significance in epilepsy
  30. Controversy over misinterpretation of EEG with subsequent misdiagnosis of epilepsy
  31. Efficacy of vagal nerve stimulation in patients with cerebral palsy: Emerging corroborative evidence
  32. The EEG: Warranting proper reading or diagnosing epilepsy?
  33. Vigabatrin administration in patients with infantile spasms: The risks
  34. EEG fast oscillations and epileptogenesis during meditation: Corroborative empirical evidence
  35. EEG-desynchronization as the major mechanism of anti-epileptic action of vagal nerve stimulation in patients with intractable seizures: Clinical neurophysiological evidence
  36. Increased parasympathetic tone as the underlying cause of asthma: A hypothesis
  37. Potential role of self-induced EEG fast oscillations in predisposition to seizures in meditators
  38. Reply to: The dilemma on treatment of the EEG
  39. Application of ‘shoe-smell’ in controlling epileptic attacks: Its origin
  40. The dilemma on treatment of the EEG: A justified perspective
  41. Significance of the EEG in the decision to initiate antiepileptic treatment in patients with epilepsy: A perspective on recent evidence
  42. Meditation: Epileptogenic versus antiepileptic influence
  43. Multidimensional significance of self-perception of seizure-precipitants in patients with epilepsy
  44. Definition of epilepsy: Significance of its revision on clinical neurophysiological basis to improve prognosis and quality of life of patients with epilepsy
  45. Evidence in support of treating interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy for an improved prognostic outcome and quality of life
  46. Definition of meditation: Seeking a consensus
  47. Endogenous anti-epileptogenic purpose of REM sleep in man: Corroborative clinical neurophysiological evidence
  48. Is meditation associated with a potential risk of addiction? Warranting a greater insight
  49. Justification of vigabatrin administration in West syndrome patients? Warranting a re-consideration for improvement in their quality of life
  50. Can transcendental meditation exercise a miraculous control over long-standing epilepsy?
  51. Influence of psychological/anxiety level on self-perception of precipitants in patients with epilepsy: Assessment by clinical neurophysiological studies
  52. Vagal nerve stimulation: Exploring its efficacy and success for an improved prognosis and quality of life in cerebral palsy patients
  53. Scientific basis behind traditional practice of application of “shoe-smell” in controlling epileptic seizures in the eastern countries
  54. Cerebral palsy: Is it truly absolutely non-progressive in nature?
  55. Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome
  56. Cerebral palsy: Interictal epileptiform discharges and cognitive impairment
  57. Treatment of interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy: Hope for a better outcome in prognosis
  58. Meditation and epilepsy: The ongoing debate
  59. Functional components of REM sleep programmed to exert natural anti-epileptogenic influence
  60. Does phenytoin play any role in prevention of Alzheimer’s disease?
  61. Mechanism of endogenous anti-epileptogenesis during rapid eye movement sleep
  62. A brief study of a possible relation of epilepsy association with meditation
  63. Meditation potentially capable of increasing susceptibility to epilepsy – A follow-up hypothesis
  64. Mechanism of vagal nerve stimulation (VNS) anti-convulsant action
  65. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome)
  66. Meditation may predispose to epilepsy: an insight into the alteration in brain environment induced by meditation
  67. Purpose of REM sleep: endogenous anti-epileptogenesis in man – a hypothesis
  68. Vagal nerve stimulation technique: enhancing its efficacy and acceptability by augmentation with auto activation and deactivation mode of operation
  69. Intractable epilepsy management: an EEG-oriented approach
  70. Electrical resection: new concept in management of focal epilepsy